Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IPHA Innate Pharma > Detailed Quotes

IPHA Innate Pharma

2.000
-0.070-3.38%
Close 09/30 16:00 ET
2.0000.0000.00%
Post Mkt Price 09/30 16:49 ET
High
2.098
Open
2.098
Turnover
29.67K
Low
1.980
Pre Close
2.070
Volume
14.82K
Market Cap
159.79M
P/E(TTM)
Loss
52wk High
6.500
Shares
79.89M
P/E(Static)
Loss
52wk Low
1.980
Float Cap
104.00M
Bid/Ask %
33.33%
Historical High
11.950
Shs Float
52.00M
Volume Ratio
1.17
Historical Low
1.980
Dividend TTM
--
Div Yield TTM
--
P/B
1.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.03%
Amplitude
5.72%
Avg Price
2.001
Lot Size
1
Float Cap
104.00M
Bid/Ask %
33.33%
Historical High
11.950
Shs Float
52.00M
Volume Ratio
1.17
Historical Low
1.980
Dividend TTM
--
P/B
1.30
Dividend LFY
--
Turnover Ratio
0.03%
Amplitude
5.72%
Avg Price
2.001
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv? Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni?, and Fran鏾is Romagn? on September 23, 1999 and is headquartered in Marseille, France.
CEO: Dr. Mondher Mahjoubi, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...